(PDF) Poorly Neutralizing Polyclonal Antibody in Vitro

Poorly Neutralizing Polyclonal Antibody in Vitro Against Coxsackievirus A16 Circulating Strains Can Prevent a Lethal Challenge in Vivo

Human Vaccines and Immunotherapeutics - United States

doi 10.1080/21645515.2018.1426420

Full Text

Abstract

Available in full text

Categories

Date

February 15, 2018

Authors

Publisher

Informa UK Limited

Related search

Different Antibody Response Against the Coxsackievirus A16 VP1 Capsid Protein: Specific or Non-Specific

Multidisciplinary

English

Polyclonal Antibody Against the DPV UL46M Protein Can Be a Diagnostic Candidate

Virology Journal

Infectious Diseases

English

Broad Neutralizing Activity of a Human Monoclonal Antibody Against H7N9 Strains From 2013 to 2017

Emerging Microbes and Infections

Infectious Diseases

English

An Anthrax Lethal Factor-Neutralizing Monoclonal Antibody Protects Rats Before and After Challenge With Anthrax Toxin

Infection and Immunity

Infectious Diseases

English

Neutralizing Antibody Affords Comparable Protection Against Vaginal and Rectal Simian/Human Immunodeficiency Virus Challenge in Macaques

Infectious Diseases

English

A Polyclonal Antibody Against Mammalian FOS Can Be Used as a Cytoplasmic Neuronal Activity Marker in a Teleost Fish

Journal of Neuroscience Methods

English

In Vitro and in Vivo Neutralizing Potential of Alangium Salvifolium Extract Against Russell’s Viper (Daboia Russelli)

Asian Journal of Pharmacy and Pharmacology

English

A Polyclonal Antibody Against Recombinant Bovine Haptoglobin Expressed inEscherichia Coli

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

English

Tc17, a Unique Subset of CD8 T Cells That Can Protect Against Lethal Influenza Challenge

Journal of Immunology

English